Search - tctmd.com

Displaying 221 - 231 of 231

Sort: Relevancy | Date

Presentation TVT 2012

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

Targeted Transseptal with TEE: For the Mitral Valve

Presenter: 204113|Saibal Kar

June 05, 2012

Presentation TVT 2012

Taped Case Study: The Watchman Procedure(2)

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

Case Study 2: A Case When Imaging Saved the Day!

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

Case Study: Concomitant Aortic Stenosis and MR

Presenter: Saibal Kar

June 03, 2012

Presentation GI2 2012

New devices for heart failure and pulmonary hypertension

Presenter: Saibal Kar

April 12, 2012

Presentation TCT 2012

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn, Saibal Kar, Ted Feldman, Donald Glower, Elyse Foster, Laura Mauri

January 03, 2012

Presentation TCT 2012

Effectiveness of Percutaneous Reduction of Significant Mitral Regurgitation of Functional Etiology in High Surgical Risk Patients.

Presenter: Michael Argenziano, William Gray, Alfredo Trento, Saibal Kar, Elyse Foster, Laura Mauri, Ted Feldman, Donald Glower

January 03, 2012

Video

» Interview

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

June 24, 2024

Partner Content

Tailoring Mitral Valve Repair Virtual Webcast

May 18, 2020

Video

TVT 2019: Leaflet Grasping Devices

June 13, 2019

Advertisement

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Targeted Transseptal with TEE: For the Mitral Valve

Taped Case Study: The Watchman Procedure(2)

Case Study 2: A Case When Imaging Saved the Day!

Case Study: Concomitant Aortic Stenosis and MR

New devices for heart failure and pulmonary hypertension

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Effectiveness of Percutaneous Reduction of Significant Mitral Regurgitation of Functional Etiology in High Surgical Risk Patients.

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

Tailoring Mitral Valve Repair Virtual Webcast

TVT 2019: Leaflet Grasping Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content